If you have been reading about certificate of analysis and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.
Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.
Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
| Property | Value | Notes |
|---|---|---|
| Appearance | Off-white to pale yellow solid | Visual description varies with purity and source |
| Solubility | Soluble in DMSO and ethanol; poorly soluble in water | Organic stock solutions are common in research |
| Typical storage | -20 °C, desiccated, protected from light | Avoid repeated freeze-thaw cycles |
| Typical analytical method | LC-MS or HPLC-UV | Reference standards are needed for quantification |
| Molar mass | Approximately 437.9 g/mol | Calculated from the reported free-base formula |
Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.
Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
Klaus Biemann (November 2, 1926 – June 2, 2016) was an Austrian-American professor of chemistry at the Massachusetts Institute of Technology. His work centered on structural analysis in organic and biochemistry. He has been called the "father of organic mass spectrometry" but was particularly noted for his role in advancing protein sequencing with tandem mass spectrometry following pioneering work conducted in this area by Michael Barber.
Ann Kihengu (2010 Africa Laureate) - Tanzanian energy distribution entrepreneur and founder of Pamoja Life, recognized for expanding solar energy and clean cookstove access in rural East Africa. Lianna Gunawan (2012 Asia-Pacific Laureate) - Indonesian footwear supply-chain executive and founder of Amanda Niaria, noted for introducing ethical manufacturing and community-based artisan sourcing to commercial footwear. Chinwe Ohajuruka (2015 Africa Laureate) - Nigerian green architect and founder of Comprehensive Design Services, specialized in producing affordable, solar-powered, and water-self-sufficient housing models for displaced populations. Temie Giwa-Tubosun (2020 Sub-Saharan Africa Fellow) - Nigerian health logistics pioneer and founder of LifeBank, a medical distribution company using tech and cold-chain infrastructure to deliver blood, oxygen, and vaccines to hospitals across Africa. Basima Abdulrahman (2021 Middle East & North Africa Laureate) - Iraqi structural engineer and founder of Kesk, recognized for establishing Iraq's first green building and sustainable engineering consultancy to build solar-powered infrastructure.
=== Pre-modern === Salting could be combined with smoking to produce bacon in peasant homes. Instructions for preserving (salting) freshly killed venison in the 14th century involved covering the animal with bracken as soon as possible and carrying it to a place where it could be butchered, boiled in brine, and dry salted for long term preservation in a barrel. People in the 14th century also put salt on vegetables for taste. Salted meat was a staple of the mariner's diet in the Age of Sail. It was stored in barrels, and often had to last for months at sea. The basic Royal Navy diet consisted of salted beef, salted pork, ship's biscuit, and oatmeal, supplemented with smaller quantities of peas, cheese and butter. Even in 1938, Eric Newby found the diet on the tall ship Moshulu to consist almost entirely of salted meat. The lack of refrigeration left little choice as the ship made voyages which could exceed 100 days passage between ports.
Diabetes was one of the first diseases described, with an Egyptian manuscript from c. 1500 BCE mentioning "too great emptying of the urine". The Ebers papyrus includes a recommendation for a drink to take in such cases. The first described cases are believed to have been type 1 diabetes. The term "diabetes" or "to pass through" was first used in 230 BCE by the Greek Apollonius of Memphis. The disease was considered rare during the time of the Roman Empire, with Galen commenting he had seen only two cases during his career. This is possibly due to the diet and lifestyle of the people of that time, or because the clinical symptoms were only observed during the advanced stage of the disease. Galen named the disease "diarrhea of the urine" (diarrhea urinosa). Indian physicians around the sixth century CE identified the disease and classified it as madhumeha or "honey urine", noting the urine would attract ants. The earliest surviving work with a detailed reference to diabetes is that of Aretaeus of Cappadocia (2nd or early 3rd century CE). He described the symptoms and the course of the disease, which he attributed to moisture and coldness, reflecting his beliefs in the "Pneumatic School" of medicine. He hypothesized a correlation between diabetes and other diseases, and he discussed differential diagnosis from a snakebite, which also provoked excessive thirst. His work remained unknown in the West until 1552, when the first Latin edition was published in Venice.
=== Archaea === In 2022, the discovery of serotonin N-acetyltransferase (SNAT)—the penultimate, rate-limiting enzyme in the melatonin biosynthetic pathway—in the archaeon Thermoplasma volcanium firmly places melatonin biosynthesis in all three major domains of life, dating back to ~4 Gya.
Sources: en.wikipedia.org
=== Pharmacokinetics === In the field of pharmacokinetics, steady state refers to the condition in which the rate of drug administration is balanced by the rate of drug elimination, resulting in a stable concentration of the drug in the bloodstream over time. This equilibrium typically occurs following repeated dosing or continuous infusion, and is used to ensure consistent therapeutic drug levels. For most drugs exhibiting first-order kinetics, steady state is generally achieved after approximately four to five half-lives, at which point the changes in plasma concentrations between doses become minimal and predictable. At steady state, drug concentrations do not remain at a single, unchanging value but rather fluctuate within a limited range bounded by peak (Cmax) and trough (Cmin) values across each dosing interval. Ideally, this range is maintained above the minimum effective (therapeutic) concentration and below the threshold for adverse effects, thereby achieving concentrations within the so-called therapeutic window.
=== Biosynthesis === α-Bungarotoxin is a peptide, therefore it undergoes the protein synthesis pathway, involving transcription and translation. The specific genes encoding for the protein are transcribed into mRNA, which is then translated via the ribosomes, leading to the synthesis of the prepropeptide. Lastly, post-translational modification and folding occur. The mature peptide is stored in the venom gland until envenomation when it gets released.
The Golgi matrix is a protein scaffold around the Golgi apparatus made up of Golgins, GRASP's and miscellaneous other proteins on the cytoplasmic side of the Golgi apparatus involved in keeping its shape and membrane stacking.
Alcohol has a variety of short-term and long-term adverse effects. Alcohol has both short-term, and long-term effects on the memory, and sleep. It also has reinforcement-related adverse effects, including alcoholism, dependence, and withdrawal. Alcohol use is directly related to considerable morbidity and mortality, for instance due to intoxication and alcohol-related health problems. The World Health Organization advises that there is no safe level of alcohol consumption. Many of the toxic and unpleasant actions of alcohol in the body are mediated by its carcinogenic byproduct acetaldehyde.
TL 2636 (M-125) is an opioid drug derived from thebaine, one of the bridged oripavine family of drugs known as the Bentley compounds which includes drugs such as buprenorphine and etorphine. TL 2636 is closely related to etorphine and is a similarly potent opioid analgesic and sedative, but at low doses is characterised by producing pronounced nausea and vomiting, with a long duration of action. It was investigated as a potential incapacitating agent but was not successful due to a poor therapeutic index.
Sources: en.wikipedia.org
=== Comorbidities === The condition is strongly associated with or caused by type 2 diabetes, insulin resistance, and metabolic syndrome (defined as at least three of the five following medical conditions: abdominal obesity, high blood pressure, high blood sugar, high serum triglycerides, and low serum high-density lipoprotein). It is also associated with:
==== Effects in preclinical studies ==== Trazodone shows antidepressant- and anxiolytic-like effects in animals. However, it shows differences from certain other antidepressants, like the tricyclic antidepressants, in animals. For example, it does not reverse the behavioral effects of the monoamine depleting agent reserpine and does not potentiate the effects of amphetamine or levodopa. Similarly to antipsychotics, trazodone reduces spontaneous motor activity, spontaneous and elicited aggressive behavior, and exploratory behavior, among other effects. In addition, trazodone diminishes amphetamine-induced locomotor hyperactivity, although it does not inhibit apomorphine- or amphetamine-induced stereotypy. On the other hand, unlike antipsychotics, trazodone does not produce catalepsy, although it can do so at sufficiently high doses. Activation of the serotonin 5-HT2A receptor enhances striatal dopaminergic neurotransmission, while stimulation of the serotonin 5-HT2C receptor inhibits striatal dopaminergic neurotransmission. Trazodone is both a serotonin 5-HT2A and 5-HT2C receptor antagonist, but has about 15-fold greater potency as an antagonist of the 5-HT2A receptor relative to the 5-HT2C receptor. In addition, at higher doses, trazodone acts as a dopamine D2 receptor antagonist in animals. As a result of the preceding actions, trazodone may inhibit striatal dopaminergic neurotransmission. This may underlie exacerbation of parkinsonism seen in marmosets and in human case reports.
== Proto metabolism and minimal metabolism == Two related but distinct concepts are important for understanding the origins of metabolism: Proto metabolism refers to the actual metabolic like chemistry that existed on prebiotic Earth. Kee and Monnard describe the "internal catalytic network, often referred to as 'metabolism'" as "the set of catalysts/catalytic assemblies that a protocell would have required to process resources into its own building blocks." Critically, early proto metabolic systems relied on external support: "From its simplest form, based on encapsulated metal-ions and complexes or even mineral particles, this reaction system would have gradually evolved first into RNA-based and, over time, into protein catalytic networks, i.e. towards metabolic bio-machinery." Minimal metabolism is a theoretical concept describing the minimum requirements for chemistry to become truly metabolic. Lauber et al. (2021) define it as "a heuristic construct, halfway between chemistry and biology" that stands "at the interface between non-equilibrium complex chemistries and biological systems." Unlike proto metabolism that describes non genetic and non enzymatic reaction networks driven by the environment, minerals, and simple organics, minimal metabolism represents the next stage: the earliest cellular metabolic system with some enzymes and genetic control, capable of supporting growth and division while still depending on environmental gradients.
== Wyld diagrams == Wyld diagrams are bookkeeping graphs that correspond to the Navier–Stokes equations via a perturbation expansion of the fundamental continuum mechanics. Similar to the Feynman diagrams in quantum field theory, these diagrams are an extension of Mstislav Keldysh's technique for nonequilibrium processes in fluid dynamics. In other words, these diagrams assign graphs to the (often) turbulent phenomena in turbulent fluids by allowing correlated and interacting fluid particles to obey stochastic processes associated to pseudo-random functions in probability distributions.
Sources: en.wikipedia.org
It is usually detected by LC-MS or HPLC-UV against a reference standard. In biological matrices, metabolite targeting can improve detection. No universal immunoassay is widely available.
The compound is generally handled as light-sensitive and stored cold and dry. Stability in solution depends on solvent, concentration, and storage time. Specific degradation rates are not fully standardized.
Limited water solubility affects formulation for cell and animal studies. Organic co-solvents are often used to dissolve it. Precipitation can confound assay results if not controlled.
It is a synthetic research compound that activates REV-ERB nuclear receptors. It is not an approved drug or dietary supplement. Most information comes from cell and animal studies.